Advances in Current Diabetes Proteomics: From the Perspectives of Label-free Quantification and Biomarker Selection.
Sign Up to like & getrecommendations! Published in 2019 at "Current drug targets"
DOI: 10.2174/1389450120666190821160207
Abstract: BACKGROUND Due to its prevalence and negative impacts on both economy and society, the diabetes mellitus (DM) has emerged as a worldwide concern. In light of this, the label-free quantification proteomics (LFQ) and diabetic marker… read more here.
Keywords: selection; free quantification; label free; computational advances ... See more keywords